| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 05/02/1997 | EP0769968A1 Retroviral vectors produced by producer cell lines resistant to lysis by human serum |
| 05/02/1997 | EP0683897B1 Method for detecting viral components using a glycoprotein |
| 05/02/1997 | EP0500917B1 Recombinant herpes simplex viruses vaccines and methods |
| 05/01/1997 | WO1997015666A1 Therapeutic antiangiogenic compositions and methods |
| 05/01/1997 | WO1997015661A1 Microporous pathogen-killing composition |
| 05/01/1997 | WO1997015331A1 Methods of preserving microorganisms |
| 05/01/1997 | CA2235832A1 Microporous pathogen-killing composition |
| 05/01/1997 | CA2235495A1 Methods of preserving microorganisms |
| 04/29/1997 | US5624795 Isolation and characterization of a novel chimpanzee lentivirus, designated simian immunodeficiency virus isolate cpz-ant |
| 04/28/1997 | CA2185407A1 Sustainable chick cell line infected with marek's disease virus |
| 04/28/1997 | CA2185406A1 Improvements in sustainable cell line for the production of marek's disease vaccines |
| 04/24/1997 | WO1996038474A3 Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide |
| 04/23/1997 | EP0769062A2 Novel internal ribosome entry site, vector containing same and therapeutical use thereof |
| 04/23/1997 | EP0768824A1 Insect control method with genetically engineered biopesticides |
| 04/22/1997 | US5622856 High efficiency helper system for AAV vector production |
| 04/22/1997 | US5622848 Electrically hydrolyzed salines as microbiocides for in vitro treatment of contaminated fluids containing blood |
| 04/17/1997 | WO1996036221A3 Insect control with multiple toxins |
| 04/17/1997 | WO1996030523A3 Antigen presentation system based on retrovirus-like particles |
| 04/17/1997 | WO1996017072A3 Recombinant alphavirus vectors |
| 04/17/1997 | CA2234604A1 Recombinant herpes virus vectors for expression in neuronal cells |
| 04/16/1997 | EP0768377A1 Generation and selection of recombinant varied binding proteins |
| 04/16/1997 | EP0767839A1 Improvements in or relating to delivery of nucleic acids |
| 04/16/1997 | EP0767677A1 Electrically hydrolyzed salines as in vivo microbicides for the treatment of cardiomyopathy and multiple sclerosis |
| 04/16/1997 | CN1147837A Recombinant adenoviral vector and methods of use |
| 04/16/1997 | CN1147833A Hepatitis A virus culture process |
| 04/16/1997 | CN1147769A Para-influenza virus-containing vaccines for preventing porcine reproductive and respiratory syndrome |
| 04/16/1997 | CN1034569C Endothelin receptor antagonists |
| 04/16/1997 | CN1034554C Producing process for cell free marek's disease virus vaccine |
| 04/15/1997 | US5620691 Polypeptide vaccine |
| 04/10/1997 | WO1997012968A1 Retroviral vectors pseudotyped with srv-3 envelope glycoprotein sequences |
| 04/10/1997 | WO1997012959A1 Method of disrupting cultured cells using an impinging jet device |
| 04/10/1997 | WO1997012622A1 Vector and method of use for nucleic acid delivery to non-dividing cells |
| 04/10/1997 | CA2234219A1 Retroviral vectors pseudotyped with srv-3 envelope glycoprotein sequences |
| 04/09/1997 | EP0766740A1 Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections |
| 04/09/1997 | EP0766569A1 Aav capsid vehicles for molecular transfer |
| 04/09/1997 | EP0766512A1 Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
| 04/09/1997 | EP0651815B1 Modified baculovirus, method for obtaining it, and expression vectors obtained from said baculovirus |
| 04/09/1997 | CN1147275A Biological insect control agent |
| 04/09/1997 | CN1147272A Spider neurotoxins and method of producing the same |
| 04/09/1997 | CN1147015A Marek's Disease Vaccine |
| 04/08/1997 | US5618723 Method of eliminating genetic routes for bacteriophage evolution and products produced thereby |
| 04/08/1997 | US5618694 Tumor diagnosis |
| 04/08/1997 | US5618536 Chimeric papillomavirus-like particles |
| 04/03/1997 | WO1997012048A1 Recombinant viruses incorporating a protease cleavable protein |
| 04/03/1997 | WO1997012032A1 Production of infectious respiratory syncytial virus from cloned nucleotide sequences |
| 04/03/1997 | WO1997011720A1 Methods for treating cancers and restenosis with p21 |
| 04/03/1997 | WO1996040948A3 Resistance to viruses and viroids in transgenic plant and animal hosts expressing dsrna-binding protein |
| 04/03/1997 | CA2232669A1 Recombinant viruses incorporating a protease cleavable protein |
| 04/02/1997 | EP0436597B1 Generation and selection of recombinant varied binding proteins |
| 04/01/1997 | US5616487 Alpha-hydro-omega-hydroxypoly(oxyethylene)polyoxypropylene block copolymer; introducing an exogenous nucleotide sequence into target cell |
| 03/27/1997 | WO1997011200A1 Human herpesvirus type 8 isolated from human lymphoma cell line and uses thereof |
| 03/27/1997 | WO1997011160A1 Method of adsorbing viruses from fluid compositions |
| 03/27/1997 | WO1997000088A3 Rotavirus enterotoxin nsp4 and methods of using same |
| 03/27/1997 | CA2232622A1 Method of adsorbing viruses from fluid compositions |
| 03/26/1997 | EP0764213A1 Recombinant aav genome encoding immunodeficiency virus protein |
| 03/26/1997 | EP0764210A1 Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests |
| 03/25/1997 | US5614405 Virus-free blood |
| 03/25/1997 | US5614404 Plasmid vector for insertion of human immunodeficiency virus dna sequences into a pox virus |
| 03/20/1997 | WO1997003187A3 Marek's disease virus genes and their use in vaccines for protection against marek's disease |
| 03/19/1997 | EP0763120A1 Safe vectors for gene therapy |
| 03/19/1997 | EP0763116A1 Recombinant viruses, preparation and use thereof in gene therapy |
| 03/19/1997 | EP0763114A2 Hepatitis g virus and molecular cloning thereof |
| 03/19/1997 | EP0763103A1 Gene delivery vector using plasmid dna packaged into an adenovirus and a packaging cell line |
| 03/19/1997 | EP0762894A1 Method of inducing an immune response with a live venezuelan equine encephalitis virus expressing a heterologous immunogen |
| 03/19/1997 | EP0762891A1 Immunogenic pharmaceuticals |
| 03/19/1997 | CN1145223A Endothelin receptor antagonists |
| 03/18/1997 | US5612217 Streptomyces sp. MA 7074 (ATCC 55605) used for microbial synthesis of HIV protease inhibitors |
| 03/18/1997 | US5612206 Retrovirus infecting primate bone marrow cells and harvesting both non-adherent and adherent cells |
| 03/13/1997 | WO1997009441A2 Improved aav vectors for gene therapy |
| 03/13/1997 | WO1997009440A1 The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells |
| 03/13/1997 | CA2230758A1 Improved aav vectors for gene therapy |
| 03/12/1997 | EP0761096A1 Insecticidal matrix and process for preparation thereof |
| 03/12/1997 | EP0760860A1 Methods of in vivo gene delivery |
| 03/12/1997 | EP0760682A1 Gene transfer-mediated angiogenesis therapy |
| 03/12/1997 | CN1145020A Ancient organisms |
| 03/11/1997 | US5610054 Enzymatic RNA molecule targeted against Hepatitis C virus |
| 03/11/1997 | US5610050 Methods of preventing viral replication |
| 03/11/1997 | US5610049 Human rotavirus HCR3A and method of growing said rotavirus |
| 03/11/1997 | US5609864 Polyvinylpyrrolidone iodine |
| 03/06/1997 | WO1997008324A1 Methods for enhancing the production of interferon in cell culture |
| 03/06/1997 | WO1997008310A1 Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof |
| 03/06/1997 | WO1997008298A1 Chromatographic purification of adenovirus and aav |
| 03/06/1997 | WO1997008297A1 Recombinant helicoverpa baculoviruses expressing heterologous dna |
| 03/06/1997 | WO1997008292A1 Methods for enhancing the production of viral vaccines in cell culture by interferon suppression |
| 03/06/1997 | WO1997008197A1 Dna sequence coding for a polypeptide which enhances virus infection of host insects |
| 03/06/1997 | WO1997007817A1 Multi-subtype fiv vaccines |
| 03/06/1997 | WO1997007674A1 Methods and compositions for the selective modification of nucleic acids |
| 03/06/1997 | WO1997005255A3 Helper viruses for preparing recombinant viral vectors |
| 03/06/1997 | CA2625279A1 Chromatographic purification of adenovirus and aav |
| 03/06/1997 | CA2230671A1 Methods and compositions for the selective modification of nucleic acids |
| 03/05/1997 | EP0760394A1 Mild Newcastle disease virus vaccine |
| 03/05/1997 | EP0760100A1 PHAGE/PHAGEMID DISPLAY LIBRARY COMPRISING RANDOMLY CLEAVED cDNA/GENOMIC DNA OR CLONED GENE |
| 03/05/1997 | EP0760013A1 Treatment of influenza virus infection using antivirals that inhibit acylation/palmitylation of hemagglutinin |
| 03/05/1997 | EP0760000A1 Alphavirus expression vector |
| 03/05/1997 | EP0759777A1 VACCINE FOR $i(MORAXELLA CATARRHALIS) |
| 03/05/1997 | CN1144536A Novel mutated viruses, anti-viral compounds and novel methods of making vaccines |
| 03/05/1997 | CN1144272A Hepatitis B surface antigen containing front surface antigen 1 and 2 immunodeterminant |
| 03/04/1997 | US5607852 Process for attenuated varicella zoster virus vaccine production |
| 03/04/1997 | US5607851 Process for purifying hepatitis a virus (HAV), and vaccine compositions containing hepatitis a virus |
| 03/04/1997 | US5607846 Vaccine for moraxella catarrhalis |